Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic

Sero-prevalence of anti-SARS-CoV-2 antibodies among communities between July and August 2022 in Bangui, Central African Republic

Background. Large-scale population-based seroprevalence studies of SARS-CoV-2 are essential to characterize the cumulative incidence of SARS-CoV-2 infection and to extrapolate the prevalence of presumptive immunity at the population level. Objective. The objective of our survey was to estimate the...

Full description

Bibliographic Details
Main Authors: Alexandre Manirakiza, Christian Malaka, Jean de Dieu Longo, Brice Martial Yambiyo, Saint-Calver Henri Diemer, Joella Namseneï, Cathy Sandra Gomelle Coti-Reckoundji, Modeste Bouhouda, Marie Roseline Darnycka Belizaire, Jean Baptiste Roungou, Narcisse Patrice Komas, Gérard Grésenguet, Guy Vernet, Marie-Astrid Vernet, Emmanuel Nakoune
Format: Article
Language:English
Published: PAGEPress Publications 2023-06-01
Series:Journal of Public Health in Africa
Subjects:
SARS-CoV-2
cumulative immunity
Bangui
Central African Republic
Online Access:https://www.publichealthinafrica.org/jphia/article/view/2315

Internet

https://www.publichealthinafrica.org/jphia/article/view/2315

Similar Items